Pulmonary Congestion and Left Ventricular Dysfunction after Myocardial Infarction: Insights from the PARADISE-MI Trial

Publikation: Bidrag til tidsskrift › Letter › Forskning › fagfællebedømt

  • Mark C. Petrie
  • Jean L. Rouleau
  • Brian Claggett
  • Karola Jering
  • Peter Van Der Meer
  • Køber, Lars Valeur
  • Zi Michael Miao
  • Eldrin Lewis
  • Christopher Granger
  • Carmine G. De Pasqulae
  • Douglas Mann
  • Philippe Gabriel Steg
  • Aldo Maggioni
  • Offer Amir
  • Marty Lefkowitz
  • Eugene Braunwald
  • Scott D. Solomon
  • John J.V. McMurray
  • Marc A. Pfeffer
OriginalsprogEngelsk
TidsskriftCirculation
Vol/bind149
Udgave nummer4
Sider (fra-til)335-338
Antal sider4
ISSN0009-7322
DOI
StatusUdgivet - 2024

Bibliografisk note

Funding Information:
PARADISE-MI (Prospective ARNI vs ACE Inhibitors Trial to Determine Superiority in Reducing Heart Failure Events After MI) was funded by Novartis. Drs Petrie and McMurray are supported by British Heart Foundation Centre of Research Excellence Awards (Nos. RE/13/5/30177 and RE/18/6/34217+).

ID: 381069098